Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

29 Sep 2010 07:00

RNS Number : 4602T
Imaginatik PLC
29 September 2010
 



 29 September 2010

Imaginatik plc

("Imaginatik" or the "Company")

 

AGM Statement

Contract Win and Management Appointments

 

At the Company's Annual General Meeting to be held later today, Matthew Cooper, Executive Chairman of Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and innovation consultancy, will make the following statement:

 

"We continue to make steady progress towards achieving our strategic goals. A new management team is now largely in place and has been further strengthened by the two recent appointments referred to below.

 

"As stated in the announcement dated 18 August 2010, we believe that it will take time to rebuild the Company's sales pipeline. However, the recently announced contract wins and a further win with the U.S. Government announced today are evidence of a growing momentum.

 

"While the re-organisation of the business earlier this year will inevitably have an impact on results for the first half of the year, we expect to see a return to more normal levels of sales in the second half.

 

"The calibre of people joining our team and the high profile customers with whom we continue to work give us confidence in the future of Imaginatik."

 

The Company also announces today a contract win and two senior management team appointments.

 

Contract to supply innovation solutions to the United States Government, General Services Administration

 

Imaginatik has been selected as a strategic innovation solutions provider by QinetiQ North America, Inc. in support of the United States Government, General Services Administration (the "GSA"). QinetiQ North America, one of the world's leading defence technology and security companies, has issued Imaginatik a six month Subcontract Agreement worth over $400,000, with one six month option period, to assist in enabling Business Transformation and Collaboration at the GSA. Under this Agreement, Imaginatik will use its Idea Central Collaboration Platform to assist GSA in identifying innovation strategies to enhance business practices. It includes licenses for GSA's 15,000 associates, facilitation and programme management support, and various training initiatives to foster collaboration at GSA.

 

Senior Appointments

 

Imaginatik is also pleased to announce it has made two recent senior appointments to strengthen the Company's sales and product development capabilities. Neither appointment is a Board position.

 

Kevin Grygiel has been appointed Global Vice-President of Sales. Based in Boston, Kevin will lead the sales organisation, reporting to Luis Solis the Vice-President of Business Development. Kevin has more than 20 years in software sales, with the last eight years at SiteScape Inc. a collaboration and social media software business. This appointment affirms the Company's commitment to bringing in high calibre sales executives with relevant expertise capable of growing the business.

 

Robin Spencer, previously Senior Research Fellow, Idea Management & Innovation at Pfizer Inc., has joined Imaginatik as Director of Research. Rob will work within the Product Development team in building out all future product enhancements and will continue Imaginatik's tradition of leading edge empirical research within our field of innovation and collaborative problem solving.

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

 

About Imaginatik

 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

 

For more information visit www.imaginatik.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDMGZLKRGGGZM
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.